Publication

Integrative transcriptomic profiling of a mouse model of hypertension-accelerated diabetic kidney disease

Disease Models & Mechanisms 14(10): dmm049086, 2021

Sembach FE, Ægidius HM, Fink LN, Secher T, Aarup A, Jelsing J, Vrang N, Feldt-Rasmussen B, Rigbolt KTG, Nielsen JC, Østergaard MV

Subjects

Adeno-associated virus (AAV)-mediated gene delivery ReninAAV UNx db/db mouse Therapeutic Area Mouse Method/Endpoint Diabetes Species Diabetic kidney disease (DKD)Bioinformatics Image analysis Immunohistochemistry Kidney morphometry RNA sequencing Single-nucleus RNA sequencing

Share this page

Resource Library

Related resources

Nephroprotective effects of semaglutide as mono- and combination treatment with lisinopril in a mouse model of hypertension-accelerated diabetic kidney disease

Nephroprotective effects of semaglutide in a preclinical model of hypertensive diabetic kidney disease

Therapeutic effects of lisinopril and empagliflozin in a mouse model of hypertension-accelerated diabetic kidney disease

Lost in translation – how to improve the translatability of rodent models of diabetic kidney disease

For further information

Contact us

Gubra

Hørsholm Kongevej 11B
2970 Hørsholm
Denmark

+45 3152 2650